Phathom Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2018-01-01
- Employees
- 452
- Market Cap
- $1B
- Website
- http://www.phathompharma.com
- Introduction
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
Phathom Pharmaceuticals Announces FDA Approval of Voquezna (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults
Phathom Pharmaceuticals announces FDA approval of Voquezna (vonoprazan) tablets for treating heartburn associated with Non-Erosive GERD in adults, marking a significant milestone for millions of GERD patients.
© Copyright 2024. All Rights Reserved by MedPath